Barclays’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,332,719
Closed -$2.07M 4581
2022
Q4
$2.07M Buy
2,332,719
+337,068
+17% +$299K ﹤0.01% 1627
2022
Q3
$3.13M Buy
1,995,651
+1,829,031
+1,098% +$2.87M ﹤0.01% 1366
2022
Q2
$335K Buy
166,620
+115,761
+228% +$233K ﹤0.01% 2828
2022
Q1
$118K Sell
50,859
-327,570
-87% -$760K ﹤0.01% 3596
2021
Q4
$1.76M Buy
378,429
+242,451
+178% +$1.13M ﹤0.01% 1880
2021
Q3
$1.04M Buy
135,978
+93,676
+221% +$715K ﹤0.01% 2234
2021
Q2
$410K Sell
42,302
-167,596
-80% -$1.62M ﹤0.01% 2575
2021
Q1
$1.74M Sell
209,898
-121,206
-37% -$1M ﹤0.01% 1972
2020
Q4
$2.26M Sell
331,104
-27,759
-8% -$189K ﹤0.01% 1501
2020
Q3
$4M Sell
358,863
-25,413
-7% -$283K ﹤0.01% 1085
2020
Q2
$2.41M Buy
384,276
+172,071
+81% +$1.08M ﹤0.01% 1346
2020
Q1
$391K Buy
212,205
+520
+0.2% +$958 ﹤0.01% 2240
2019
Q4
$716K Buy
211,685
+116,107
+121% +$393K ﹤0.01% 2489
2019
Q3
$205K Buy
95,578
+20,162
+27% +$43.2K ﹤0.01% 3049
2019
Q2
$201K Buy
75,416
+42,985
+133% +$115K ﹤0.01% 3195
2019
Q1
$154K Sell
32,431
-71,241
-69% -$338K ﹤0.01% 3146
2018
Q4
$249K Buy
103,672
+22,157
+27% +$53.2K ﹤0.01% 2636
2018
Q3
$359K Buy
81,515
+44,436
+120% +$196K ﹤0.01% 2791
2018
Q2
$267K Sell
37,079
-68,421
-65% -$493K ﹤0.01% 2602
2018
Q1
$543K Sell
105,500
-4,644
-4% -$23.9K ﹤0.01% 2243
2017
Q4
$419K Buy
110,144
+79,444
+259% +$302K ﹤0.01% 2216
2017
Q3
$52K Buy
30,700
+3,700
+14% +$6.27K ﹤0.01% 2937
2017
Q2
$54K Buy
27,000
+25,532
+1,739% +$51.1K ﹤0.01% 2994
2017
Q1
$6K Buy
1,468
+822
+127% +$3.36K ﹤0.01% 3623
2016
Q4
$3K Buy
+646
New +$3K ﹤0.01% 3553
2014
Q3
Sell
-1,000
Closed -$6K 4474
2014
Q2
$6K Buy
+1,000
New +$6K ﹤0.01% 3855